Claritev Q2 Earnings Call Highlights
Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.
How this was made
The 30-second read
Why it matters
The Q2 call highlights stronger bookings and pipeline, plus raised FY revenue, EBITDA, and free-cash-flow outlook, with AI initiatives aimed at reducing IDR administrative costs.
Market read
Traders can reprice Claritev’s growth and margin expectations based on raised FY guidance and bookings/pipeline acceleration, while monitoring the flat sequential Q3 revenue comment.
What to watch
About 75% of bookings come from cross-sell/upsell, so churn or consolidation risk at existing clients could matter more than new-logo growth.
Background
Claritev provides healthcare network, payment integrity, and related solutions tied to claims repricing and No Surprises Act workflows.
Ticker impact
Claritev raised full-year revenue guidance to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M after Q2 performance.
Likely positive near-term bias as guidance and bookings targets reset expectations, though execution risk remains given multi-quarter revenue ramp.
The article provides specific, time-sensitive guidance ranges and bookings/pipeline metrics, which typically move valuation expectations for growth and margin trajectory.
Market effects
Reinforces demand for healthcare payment integrity and No Surprises Act workflow platforms, supporting sentiment for adjacent healthcare data/claims repricing vendors.
No clear regional-specific impact described.
Primarily US regulatory-driven demand (No Surprises Act), limited direct global read-through in the text.
Counterpoint
Guidance is raised but Q3 revenue is guided roughly flat sequentially, implying near-term growth may still be uneven.
Key entities
- companyClaritev
Healthcare technology and data insights provider focused on affordability, transparency, and payment integrity.
- personTravis Dalton
CEO who discussed TPA contracts, Medicare Advantage network build, and AI initiatives.
- personGaris
Speaker who discussed No Surprises Act revenue drivers, bookings mix, and ProPricer AI savings.
